Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
8252912
Publication Date
8-28-2012
Abstract
The present disclosure relates to a sodium iodide symporter (NIS)-repressor binding site (NRBS) consisting of a DNA molecule spanning from −645 to −605 nucleotides (SEQ ID NO:4) or from −648 to −620 nucleotides (SEQ ID NO:5) upstream from the translation start site of human NIS gene. The disclosure further relates to a method of restoring iodide transport to a human thyroid carcinoma cell, including: the steps of: i) contacting the cell expressing and forming a NIS repressor protein complex capable of binding to the NRBS of the disclosure with a modulator of said complex, and ii) administering to the cell radiolabeled iodide.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
12/081,790
Filing Date
04/21/2008
Recommended Citation
Ain, Kenneth B. and Li, Wei, "Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma" (2012). Internal Medicine Faculty Patents. 1.
https://uknowledge.uky.edu/internalmedicine_patents/1
